Global Multiomics Market Projected to Grow at 16.6% CAGR, Reaching $7.11 Billion by 2029

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Multiomics Industry Market Size Be by 2025?
The multiomics sector has experienced swift expansion over the past few years, projected to increase its market valuation from $3.27 billion in 2024 to $3.85 billion by 2025, reflecting a compound annual growth rate (CAGR) of 17.7%; this upward trajectory during the historical timeframe is attributable to several factors, including elevated levels of biomedical investigation, greater investment from both public and private sources, a surge in the incidence rates of long-term illnesses, ongoing technological progress, and the availability of more sophisticated computational resources and applications for analyzing complex data.

What's the Long-Term Growth Forecast for the Multiomics Market Size Through 2029?
Anticipating a swift expansion in the forthcoming years, the overall size of the multiomics market is projected to reach $7.11 billion by 2029, propelled by a compound annual growth rate (CAGR) of 16.6%. This upward trajectory throughout the predicted period is fueled by several key factors, such as progress in artificial intelligence and machine learning technologies, the broadening scope of clinical uses, the expanding biopharmaceutical sector, the introduction of unified multiomics solutions, and the heightened application within agricultural and environmental studies. Significant developments shaping the market during this forecast timeframe involve ongoing technological innovation, the release of novel commercial multiomics systems, increased implementation of spatially resolved multiomics analysis, greater integration into biopharmaceutical research and development efforts, and the penetration of multiomics into the realm of clinical diagnostics.

View the full report here:
https://www.thebusinessresearchcompany.com/report/multiomics-global-market-report

What Are the Key Growth Drivers Fueling the Multiomics Market Expansion?
Advancements in personalized medicine are projected to significantly boost the expansion of the multiomics sector in the near future. Personalized medicine constitutes a medical methodology where healthcare choices and interventions are specifically adapted to each patient, taking into account their unique genetic makeup, environment, and lifestyle habits. This individualized healthcare trend is gaining traction, fueled by progress in technology, a greater need for highly specific therapies, and global enhancements in the medical field. Multiomics plays a crucial role in facilitating personalized medicine by offering an in-depth analysis of a person's genomic, molecular, and metabolic blueprint, thereby empowering clinicians to customize treatments aligned with the precise attributes of every individual. As an illustration, data from the Personalized Medicine Coalition, an organization situated in the United States, indicates that the FDA authorized 16 new personalized treatments for individuals suffering from uncommon illnesses throughout 2023, marking an increase from the 6 authorizations granted in 2022. Consequently, the surging requirement for tailored medical solutions serves as a key impetus behind the expansion observed in the multiomics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15866&type=smp

What Are the Key Trends Driving Multiomics Market Growth?
Key players within the multiomics sector are focusing efforts on creating sophisticated single-cell multiomics systems designed to facilitate expansive research endeavors while preserving the quality of biological samples. These single-cell multiomics solutions incorporate diverse omics data streams alongside artificial intelligence features, empowering users to effortlessly examine and make sense of intricate biological datasets by employing advanced computational methods and machine learning. As a concrete illustration, in the month of February in 2023, the United States firm Becton, dic*kinson, and Company introduced the BD Rhapsody HT Xpress, which represents a high-volume single-cell multiomics platform; this groundbreaking setup permits researchers to carry out the isolation, barcoding, and examination of individual cells at significantly higher processing rates, managing sample loads up to eight times greater than what prior BD single-cell analysis tools could handle. Furthermore, the BD Rhapsody HT Xpress System guarantees zero sample degradation and provides the adaptability required to concurrently process various samples alongside different cellular dimensions and classifications, including elements like progenitor cells or malignant cells, thereby boosting the capacity for researchers to achieve deeper understandings more rapidly.

How Is the Multiomics Market Segmented?
The multiomicsmarket covered in this report is segmented -

1) By Type: Single-Cell Multiomics; Bulk Multiomics
2) By Platform: Genomics; Transcriptomics; Proteomics; Metabolomics; Integrated Omics Platforms
3) By Application: Diagnostics; Drug Discovery And Development; Personalized Medicine; AgriGenomics; Other Applications
4) By End User: Academics And Research Organization; Pharmaceutical And Biotechnology Companies; Clinical research Organization; Other End-Users

Subsegments:
1) By Single-Cell Multiomics: Single-Cell Genomics; Single-Cell Transcriptomics; Single-Cell Epigenomics; Single-Cell Proteomics; Single-Cell Metabolomics
2) By Bulk Multiomics: Genomics; Transcriptomics; Epigenomics; Proteomics; Metabolomics

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15866&type=smp

Which Companies Are Leading the Charge in Multiomics Market Innovation?
Major companies operating in the multiomics market are Bayer AG, Thermo Fisher Scientific Inc., Novartis AG, Becton dic*kinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Shimadzu Corporation, Bruker Corporation, Bio-Techne, Azenta Life Sciences, 10x Genomics, Ginkgo Bioworks, Abcam limited, BioLegend, Oxford Nanopore Technologies Plc, Adaptive Biotechnologies, Pacific Biosciences, Standard BioTools, Parse Biosciences, Mission Bio, CD Genomics, Singleron Biotechnologies, Psomagen, BGI Group

Which Regions Are Leading the Global Multiomics Market in Revenue?
North America was the largest region in the multiomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15866

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.